INOZYME

What this means for you

Registered since 16 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

90439231

Registration number

8069672

Mark type

Stylized text

Filed

31 Dec 2020

Published for opposition

22 Mar 2022

Registered

16 Dec 2025

Attorney of record

Gregory J. Chinlund

Goods and services

• Class 005 — Pharmaceuticals: therapeutic pharmaceutical for the diagnosis and treatment of diseases or disorders afflicting the bone, kidney and tissue, diseases of abnormal mineralization and calcification, diseases of the circulatory system, diseases caused by inborn errors of metabolism, and diseases caused by abnormal intimal proliferation; pharmaceutical products for use in the diagnosis and treatment of bone, kidney and tissue diseases, diseases of abnormal mineralization and calcification, diseases of the circulatory system, diseases caused by inborn errors of metabolism, and diseases caused by abnormal intimal proliferation

Owner

• Inozyme Pharma, Inc., Boston, MA, US
• Inozyme Pharma, Inc., Boston, MA, US
• Inozyme Pharma, Inc., Boston, MA, US

Prosecution history

• 16 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 16 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
• 26 Nov 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 26 Nov 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 21 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
• 15 May 2025 — USE AMENDMENT FILED
• 21 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 19 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 19 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 19 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 19 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 19 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 15 May 2025 — TEAS STATEMENT OF USE RECEIVED
• 07 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 07 Nov 2024 — SOU EXTENSION 5 GRANTED